UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.002

Sortiert nach

Targeting RET-driven cancers: lessons from evolving preclinical and clinical landscapes

Nature reviews. Clinical oncology, 2018-03, Vol.15 (3), p.151-167

2018

Volltextzugriff (PDF)

Artificial tactile and proprioceptive feedback improves performance and confidence on object identification tasks

PloS one, 2018-12, Vol.13 (12), p.e0207659-e0207659

2018

Volltextzugriff (PDF)

Novel therapeutic targets on the horizon for lung cancer

The lancet oncology, 2016-08, Vol.17 (8), p.e347-e362

2016

Volltextzugriff (PDF)

A neural interface provides long-term stable natural touch perception

Science translational medicine, 2014-10, Vol.6 (257), p.257ra138

2014

Volltextzugriff (PDF)

Single cell analysis in head and neck cancer reveals potential immune evasion mechanisms during early metastasis

Nature communications, 2023-03, Vol.14 (1), p.1680-1680, Article 1680

2023

Volltextzugriff (PDF)

Vitamin E therapy beyond cancer: Tocopherol versus tocotrienol

Pharmacology & therapeutics (Oxford), 2016-06, Vol.162, p.152-169

2016

Volltextzugriff (PDF)

Risk of hepatitis B virus (HBV) reactivation in hepatitis B surface antigen negative/hepatitis B core antibody positive patients receiving rituximab-containing combination chemotherapy without routine antiviral prophylaxis

Annals of hematology, 2011-10, Vol.90 (10), p.1219-1223

2011

Volltextzugriff (PDF)

Influence of afatinib dose on outcomes of advanced EGFR-mutant NSCLC patients with brain metastases

BMC cancer, 2018-12, Vol.18 (1), p.1198-1198, Article 1198

2018

Volltextzugriff (PDF)

A common MET polymorphism harnesses HER2 signaling to drive aggressive squamous cell carcinoma

Nature communications, 2020-03, Vol.11 (1), p.1556-1556, Article 1556

2020

Volltextzugriff (PDF)

Anti-cancer drug resistance: Understanding the mechanisms through the use of integrative genomics and functional RNA interference

European journal of cancer (1990), 2010-08, Vol.46 (12), p.2166-2177

2010

Volltextzugriff (PDF)

Landscape of germline pathogenic variants in patients with dual primary breast and lung cancer

Human genomics, 2023-07, Vol.17 (1), p.66-66, Article 66

2023

Volltextzugriff (PDF)

Correction: Landscape of germline pathogenic variants in patients with dual primary breast and lung cancer

Human genomics, 2023-08, Vol.17 (1), p.74-74, Article 74

2023

Volltextzugriff (PDF)

Pralsetinib for RET fusion-positive non-small-cell lung cancer (ARROW): a multi-cohort, open-label, phase 1/2 study

The lancet oncology, 2021-07, Vol.22 (7), p.959-969

2021

Volltextzugriff (PDF)

Aeroallergens Induce Reactive Oxygen Species Production and DNA Damage and Dampen Antioxidant Responses in Bronchial Epithelial Cells

The Journal of immunology (1950), 2017-07, Vol.199 (1), p.39-47

2017

Volltextzugriff (PDF)

House dust mite–induced asthma causes oxidative damage and DNA double-strand breaks in the lungs

Journal of allergy and clinical immunology, 2016-07, Vol.138 (1), p.84-96.e1

2016

Volltextzugriff (PDF)

Long noncoding RNA EGFR-AS1 mediates epidermal growth factor receptor addiction and modulates treatment response in squamous cell carcinoma

Nature medicine, 2017-10, Vol.23 (10), p.1167-1175

2017

Volltextzugriff (PDF)

Intertumor heterogeneity of non‐small‐cell lung carcinomas revealed by multiplexed mutation profiling and integrative genomics

International journal of cancer, 2014-09, Vol.135 (5), p.1092-1100

2014

Volltextzugriff (PDF)

Ceritinib in ALK-Rearranged Non–Small-Cell Lung Cancer

The New England journal of medicine, 2014-03, Vol.370 (13), p.1189-1197

2014

Volltextzugriff (PDF)

Andrographolide Restores Steroid Sensitivity To Block Lipopolysaccharide/IFN-γ-Induced IL-27 and Airway Hyperresponsiveness in Mice

The Journal of immunology (1950), 2016-06, Vol.196 (11), p.4706-4712

2016

Volltextzugriff (PDF)

Correction to: Influence of afatinib dose on outcomes of advanced EGFR-mutant NSCLC patients with brain metastases

BMC cancer, 2018-12, Vol.18 (1), p.1288-1288, Article 1288

2018

Volltextzugriff (PDF)

Anti-malarial drug, artemisinin and its derivatives for the treatment of respiratory diseases

Pharmacological research, 2020-08, Vol.158, p.104901-104901, Article 104901

2020

Volltextzugriff (PDF)

1 – 25 von 1.002

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(921)
Mit Volltextzugriff
(881)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Clinical Oncology
(22)
The Astronomical Journal
(20)
Journal Of Thoracic Oncology
(17)
Cancer Research
(15)
The New England Journal Of Medicine
(15)
Clinical Cancer Research
(14)
Climate Of The Past
(12)
Nature Communications
(12)
Nature Genetics
(11)
The astronomical Journal
(11)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Targeting RET-driven cancers: lessons from evolving preclinical and clinical landscapes

Artificial tactile and proprioceptive feedback improves performance and confidence on object identification tasks

Novel therapeutic targets on the horizon for lung cancer

A neural interface provides long-term stable natural touch perception

Single cell analysis in head and neck cancer reveals potential immune evasion mechanisms during early metastasis

Vitamin E therapy beyond cancer: Tocopherol versus tocotrienol

Risk of hepatitis B virus (HBV) reactivation in hepatitis B surface antigen negative/hepatitis B core antibody positive patients receiving rituximab-containing combination chemotherapy without routine antiviral prophylaxis

Influence of afatinib dose on outcomes of advanced EGFR-mutant NSCLC patients with brain metastases

A common MET polymorphism harnesses HER2 signaling to drive aggressive squamous cell carcinoma

Anti-cancer drug resistance: Understanding the mechanisms through the use of integrative genomics and functional RNA interference

Landscape of germline pathogenic variants in patients with dual primary breast and lung cancer

Entrectinib in ROS1 fusion-positive non-small-cell lung cancer: integrated analysis of three phase 1–2 trials

First-line ceritinib versus platinum-based chemotherapy in advanced ALK -rearranged non-small-cell lung cancer (ASCEND-4): a randomised, open-label, phase 3 study

Correction: Landscape of germline pathogenic variants in patients with dual primary breast and lung cancer

Human Innate Lymphoid Cell Subsets Possess Tissue-Type Based Heterogeneity in Phenotype and Frequency

Pralsetinib for RET fusion-positive non-small-cell lung cancer (ARROW): a multi-cohort, open-label, phase 1/2 study

Aeroallergens Induce Reactive Oxygen Species Production and DNA Damage and Dampen Antioxidant Responses in Bronchial Epithelial Cells

House dust mite–induced asthma causes oxidative damage and DNA double-strand breaks in the lungs

Long noncoding RNA EGFR-AS1 mediates epidermal growth factor receptor addiction and modulates treatment response in squamous cell carcinoma

Intertumor heterogeneity of non‐small‐cell lung carcinomas revealed by multiplexed mutation profiling and integrative genomics

Activity and safety of ceritinib in patients with ALK -rearranged non-small-cell lung cancer (ASCEND-1): updated results from the multicentre, open-label, phase 1 trial

Ceritinib in ALK-Rearranged Non–Small-Cell Lung Cancer

Andrographolide Restores Steroid Sensitivity To Block Lipopolysaccharide/IFN-γ-Induced IL-27 and Airway Hyperresponsiveness in Mice

Correction to: Influence of afatinib dose on outcomes of advanced EGFR-mutant NSCLC patients with brain metastases

Anti-malarial drug, artemisinin and its derivatives for the treatment of respiratory diseases

Suchergebnisse filtern